ProKidney
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ProKidney and other ETFs, options, and stocks.About PROK
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD.
PROK Key Statistics
Stock Snapshot
ProKidney(PROK) stock is priced at $1.76, giving the company a market capitalization of 516.52M. It carries a P/E multiple of -3.25.
During the trading session on 2026-06-08, ProKidney(PROK) shares reached a daily high of $1.82 and a low of $1.69. At a current price of $1.76, the stock is +4.3% higher than the low and still -3.1% under the high.
Trading activity shows a volume of 998.72K, compared to an average daily volume of 1.22M.
The stock's 52-week range extends from a low of $0.54 to a high of $7.13.
The stock's 52-week range extends from a low of $0.54 to a high of $7.13.
PROK News
...
ProKidney (PROK) announced the appointment of Kenneth Locke as chief technical officer. Locke joins ProKidney from Carisma Therapeutics (CARM), where he oversaw...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.